Ocular Therapeutix, Inc. To Report Fourth Quarter And Full Year 2014 Financial Results

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2014, on Tuesday, March 10, 2015. Following distribution of the earnings release via wire services, the Ocular management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to review the Company's financial results and provide a business update.

Help employers find you! Check out all the jobs and post your resume.